查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591790

幽門螺旋桿菌診斷市場：按技術、按最終用戶分類 - 2025-2030 年全球預測

Helicobacter Pylori Diagnostics Market by Technology (Immunoassays, Molecular Diagnostics, POC), End User (Clinics, Diagnostics Laboratories, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年幽門螺旋桿菌診斷市值為7.5281億美元，預計到2024年將達到8.2228億美元，複合年成長率為9.71%，到2030年將達到14.4046億美元。

幽門螺旋桿菌（H. pylori）診斷市場是胃腸病學的關鍵市場，專注於幽門螺旋桿菌引起的感染疾病的檢測和管理，幽門螺旋桿菌因與消化性潰瘍和胃癌有關而臭名昭著。該市場包括多種診斷方法，從呼吸檢測、糞便檢驗和切片檢查等無創技術，到內視鏡活體組織切片和 PCR 測試等侵入性方法。幽門螺旋桿菌準確診斷的必要性源自於幽門螺旋桿菌與胃腸道疾病密切相關，早期準確檢測對於最佳化治療效果和預防併發症至關重要。診斷技術已應用到各個地方，包括醫院、診斷實驗室和診所，全球對個人化醫療的推動也越來越重視即時檢測。市場的成長是由患病率的增加、診斷準確性的技術進步以及公眾對胃腸道健康意識的提高所推動的。然而，先進診斷工具高成本、報銷政策不一致以及潛在的抗生素抗藥性等挑戰正在阻礙市場擴張。關鍵的成長機會存在於快速且具成本效益的篩檢技術的開發中，特別是在醫療保健機會有限的新興市場。對自動化診斷平台的研發投資以及預測診斷人工智慧的整合可以帶來突破。鼓勵企業專注於與醫療保健提供者合作，並投資用於遠距離診斷的遠端醫療技術。儘管存在監管障礙和低度開發地區缺乏意識等限制，但該市場尤其受到非侵入性檢測解決方案、人工智慧主導的分析工具以及支持基於價值的護理的綜合醫療網路的推動，這提供了一條利潤豐厚的創新路徑。為了真正脫穎而出，公司應優先考慮旨在傳播醫療專業人員幽門螺旋桿菌檢測通訊協定的培訓計劃，以確保全面的市場滲透和持續成長。

主要市場統計
基準年[2023] 75281萬美元
預測年份 [2024] 82228萬美元
預測年份 [2030] 1,440.46 百萬美元
複合年成長率（%） 9.71%

市場動態：快速發展的幽門螺旋桿菌診斷市場的關鍵市場洞察

供需的動態交互作用正在改變幽門螺旋桿菌診斷市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 感染疾病流行率不斷上升
    • 提高人們對幽門螺旋桿菌的認知
    • 對早期發現症狀的需求不斷成長
  • 市場限制因素
    • 嚴格的政府監管標準
  • 市場機會
    • 對個人化抗生素治療的需求不斷成長
    • 診斷技術進步迅速成長
  • 市場挑戰
    • 來自競爭市場的競爭定價壓力

波特五力：駕馭幽門螺旋桿菌診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解幽門螺旋桿菌診斷市場的外部影響

外部宏觀環境因素在塑造幽門螺旋桿菌診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解幽門螺旋桿菌診斷市場的競爭狀況

對幽門螺旋桿菌診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣幽門螺旋桿菌診斷市場供應商的績效評估

FPNV定位矩陣是評估幽門螺旋桿菌診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，繪製幽門螺旋桿菌診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對幽門螺旋桿菌診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病傳播加劇
      • 提高人們對幽門螺旋桿菌的認知
      • 對早期發現症狀的需求增加
    • 抑制因素
      • 嚴格的政府監管標準
    • 機會
      • 對個人化抗生素治療的需求不斷增加
      • 診斷產品技術進步迅速成長
    • 任務
      • 市場競爭帶來價格戰壓力
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章幽門螺旋桿菌診斷市場：依技術分類

  • 免疫檢測
  • 分子診斷
  • 證券

第7章 幽門螺旋桿菌診斷市場：依最終使用者分類

  • 診所
  • 診斷實驗室
  • 醫院

第8章美洲幽門螺旋桿菌診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區幽門螺旋桿菌診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲幽門螺旋桿菌診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Alpha Laboratories Ltd.
  • Bio-Rad Laboratories, Inc
  • Biohit Oyj
  • CerTest BIOTEC
  • Coris BioConcept SPRL
  • Diasorin SPA
  • EKF Diagnostics Holdings PLC
  • Epitope Diagnostics, Inc.
  • Medline Industries, LP
  • Meridian Bioscience, Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • TechLab, Inc.
  • Thermo Fisher Scientific Holdings, Inc.
Product Code: MRR-CA17E905E785

The Helicobacter Pylori Diagnostics Market was valued at USD 752.81 million in 2023, expected to reach USD 822.28 million in 2024, and is projected to grow at a CAGR of 9.71%, to USD 1,440.46 million by 2030.

The Helicobacter Pylori (H. pylori) diagnostics market is pivotal in gastroenterology, focusing on the detection and management of infections caused by H. pylori bacteria, infamous for its role in peptic ulcers and gastric cancers. This market encompasses a variety of diagnostic modalities, including non-invasive techniques like breath, stool, and blood tests, as well as invasive methods such as endoscopy with biopsy and PCR tests. The necessity of accurate H. pylori diagnostics stems from the bacterium's significant contribution to gastrointestinal diseases, necessitating early and precise detection to optimize treatment efficacy and prevent complications. Diagnostics find applications across hospitals, diagnostic laboratories, and clinics, with a growing emphasis on point-of-care testing given the global push towards personalized medicine. Market growth is fuelled by increasing prevalence rates, technological advancements in diagnostic accuracy, and rising public awareness about gastrointestinal health. However, challenges such as the high cost of advanced diagnostic tools, inconsistent reimbursement policies, and potential antibiotic resistance hinder its expansion. Key growth opportunities exist in the development of rapid, cost-effective screening techniques, particularly in emerging markets where access to healthcare can be limited. Investment in R&D on automated diagnostic platforms and integration of artificial intelligence for predictive diagnostics offers potential breakthroughs. Companies are recommended to focus on partnerships with healthcare providers and invest in telemedicine technologies to tap into remote diagnostics. Despite limitations such as regulatory hurdles and low awareness in underdeveloped regions, the market presents lucrative innovation avenues, particularly in non-invasive testing solutions, AI-driven analytical tools, and integrated healthcare networks that support value-based care. To truly excel, businesses should prioritize training programs aimed at increasing the uptake of H. pylori testing protocols among healthcare professionals to ensure comprehensive market penetration and sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 752.81 million
Estimated Year [2024] USD 822.28 million
Forecast Year [2030] USD 1,440.46 million
CAGR (%) 9.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Helicobacter Pylori Diagnostics Market

The Helicobacter Pylori Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of infectious diseases
    • Increasing awareness of helicobacter pylori
    • Rise in demand early detection of symptoms
  • Market Restraints
    • Stringent regulatory norms by government
  • Market Opportunities
    • Emerging need for personalized antibiotic therapy
    • Surging technological advancement in diagnostics products
  • Market Challenges
    • Competitive pricing pressure due to highly competitive market

Porter's Five Forces: A Strategic Tool for Navigating the Helicobacter Pylori Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Helicobacter Pylori Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Helicobacter Pylori Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Helicobacter Pylori Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Helicobacter Pylori Diagnostics Market

A detailed market share analysis in the Helicobacter Pylori Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Helicobacter Pylori Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Helicobacter Pylori Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Helicobacter Pylori Diagnostics Market

A strategic analysis of the Helicobacter Pylori Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Helicobacter Pylori Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Laboratories Ltd., Bio-Rad Laboratories, Inc, Biohit Oyj, CerTest BIOTEC, Coris BioConcept SPRL, Diasorin S.P.A., EKF Diagnostics Holdings PLC, Epitope Diagnostics, Inc., Medline Industries, LP, Meridian Bioscience, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, TechLab, Inc., and Thermo Fisher Scientific Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Helicobacter Pylori Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Immunoassays, Molecular Diagnostics, and POC.
  • Based on End User, market is studied across Clinics, Diagnostics Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of infectious diseases
      • 5.1.1.2. Increasing awareness of helicobacter pylori
      • 5.1.1.3. Rise in demand early detection of symptoms
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory norms by government
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging need for personalized antibiotic therapy
      • 5.1.3.2. Surging technological advancement in diagnostics products
    • 5.1.4. Challenges
      • 5.1.4.1. Competitive pricing pressure due to highly competitive market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Helicobacter Pylori Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunoassays
  • 6.3. Molecular Diagnostics
  • 6.4. POC

7. Helicobacter Pylori Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Diagnostics Laboratories
  • 7.4. Hospitals

8. Americas Helicobacter Pylori Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Helicobacter Pylori Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Helicobacter Pylori Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alpha Laboratories Ltd.
  • 3. Bio-Rad Laboratories, Inc
  • 4. Biohit Oyj
  • 5. CerTest BIOTEC
  • 6. Coris BioConcept SPRL
  • 7. Diasorin S.P.A.
  • 8. EKF Diagnostics Holdings PLC
  • 9. Epitope Diagnostics, Inc.
  • 10. Medline Industries, LP
  • 11. Meridian Bioscience, Inc.
  • 12. Quest Diagnostics Incorporated
  • 13. Quidel Corporation
  • 14. Sekisui Diagnostics, LLC
  • 15. TechLab, Inc.
  • 16. Thermo Fisher Scientific Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. HELICOBACTER PYLORI DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HELICOBACTER PYLORI DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023